180 Financial Statements From 2010 to 2025
| ATNF Stock | USD 7.04 0.57 7.49% |
Check 180 Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 180 Life's main balance sheet or income statement drivers, such as , as well as many indicators such as . 180 financial statements analysis is a perfect complement when working with 180 Life Valuation or Volatility modules.
Check out the analysis of 180 Life Correlation against competitors. 180 Life Sciences Company Shares Owned By Insiders Analysis
180 Life's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current 180 Life Shares Owned By Insiders | 2.46 % |
Most of 180 Life's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 180 Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 2.46% of 180 Life Sciences are shares owned by insiders. This is 83.79% lower than that of the Biotechnology sector and 82.65% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 75.62% higher than that of the company.
180 Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining 180 Life's current stock value. Our valuation model uses many indicators to compare 180 Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 180 Life competition to find correlations between indicators driving 180 Life's intrinsic value. More Info.180 Life Sciences is rated below average in return on equity category among its peers. It is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value 180 Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About 180 Life Financial Statements
180 Life stakeholders use historical fundamental indicators, such as 180 Life's revenue or net income, to determine how well the company is positioned to perform in the future. Although 180 Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in 180 Life's assets and liabilities are reflected in the revenues and expenses on 180 Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in 180 Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company was incorporated in 2016 and is headquartered in Palo Alto, California. 180 Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Currently Active Assets on Macroaxis
| RYCEY | Rolls Royce Holdings | |
| VSAT | ViaSat Inc | |
| CIG | Companhia Energetica de | |
| ATEX | Anterix | |
| BBAI | BigBearai Holdings |
Check out the analysis of 180 Life Correlation against competitors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 180 Life. If investors know 180 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 180 Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of 180 Life Sciences is measured differently than its book value, which is the value of 180 that is recorded on the company's balance sheet. Investors also form their own opinion of 180 Life's value that differs from its market value or its book value, called intrinsic value, which is 180 Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 180 Life's market value can be influenced by many factors that don't directly affect 180 Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 180 Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if 180 Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 180 Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.